Mar. Drugs 2009, 7(2), 210-248; doi:10.3390/md7020210
Review

Antitumor Compounds from Marine Actinomycetes

email, email and * email
Received: 25 May 2009; in revised form: 8 June 2009 / Accepted: 11 June 2009 / Published: 11 June 2009
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Chemotherapy is one of the main treatments used to combat cancer. A great number of antitumor compounds are natural products or their derivatives, mainly produced by microorganisms. In particular, actinomycetes are the producers of a large number of natural products with different biological activities, including antitumor properties. These antitumor compounds belong to several structural classes such as anthracyclines, enediynes, indolocarbazoles, isoprenoides, macrolides, non-ribosomal peptides and others, and they exert antitumor activity by inducing apoptosis through DNA cleavage mediated by topoisomerase I or II inhibition, mitochondria permeabilization, inhibition of key enzymes involved in signal transduction like proteases, or cellular metabolism and in some cases by inhibiting tumor-induced angiogenesis. Marine organisms have attracted special attention in the last years for their ability to produce interesting pharmacological lead compounds.
Keywords: anthracycline; indolocarbazole; macrolide; non-ribosomal peptide synthetase; polyketide synthase
PDF Full-text Download PDF Full-Text [346 KB, uploaded 11 June 2009 09:49 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Olano, C.; Méndez, C.; Salas, J.A. Antitumor Compounds from Marine Actinomycetes. Mar. Drugs 2009, 7, 210-248.

AMA Style

Olano C, Méndez C, Salas JA. Antitumor Compounds from Marine Actinomycetes. Marine Drugs. 2009; 7(2):210-248.

Chicago/Turabian Style

Olano, Carlos; Méndez, Carmen; Salas, José A. 2009. "Antitumor Compounds from Marine Actinomycetes." Mar. Drugs 7, no. 2: 210-248.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert